
Izvēlieties etiķeti
redzama tieši uz flakona3 laboratorijas ziņojumi
PDF- Pārbaudīts
- Tesamorelin 10mg
- Laboratorija
- Analiza Białek
- Datums
- November 2026
- Rezultāts
- 99% purity (10.54 mg measured)
- Endotoksīni
- 4.97 EU/vial
- Pasūtījuma nr.
- Parole
PDF- Pārbaudīts
- Tesamorelin 20mg
- Laboratorija
- Analiza Białek
- Datums
- November 2026
- Rezultāts
- 99% purity (20.99 mg measured)
- Endotoksīni
- 5.59 EU/vial
- Pasūtījuma nr.
- Parole
PDF- Pārbaudīts
- Tesamorelin 5mg
- Laboratorija
- Analiza Białek
- Datums
- August 2026
- Rezultāts
- 99% purity (5.11 mg measured)
- Endotoksīni
- 3.88 EU/vial
- Pasūtījuma nr.
- Parole
Neatkarīgi pārbaudīts, ar paroli pārbaudāms tieši laboratorijā.
Tesamorelin
Fat Loss
- Laboratorijā pārbaudīts · 99% tīrība
- Sūtām no Vācijas
Pasūtījums
- DHL ar izsekošanu
- Diskrēts iepakojums
Īsumā
Tesamorelin skaitļos
Galvenie rādītāji no mūsu leksikona. Velciet punktu pa līkni, lai redzētu, cik daudz paliek pēc vienas devas, pēc aprēķina.
Pilns leksikona ierakstsHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~32 minutes
Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 26 to 38 minutes, we calculate with the middle.
Half-life
26to38minutes
after 14 days of dosing
- Class
- GHRH analogueGH secretagogue
- Frequency
- Dailysubcutaneous, usually evening
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 2 to 20 mg4 sizes in the shop
What studies show
All 3 sources in the lexiconStudy on visceral fat and liver fat (opens in a new tab)
Stanley et al., JAMA, 2014Study on cognitive performance in older subjects (GHRH) (opens in a new tab)
Baker et al., Archives of Neurology, 2012
Zināšanas
Viss par Tesamorelin
Detalizēta informācija drīzumā.
Dozēšana
Ielādē dozēšanas informāciju …
Noderēs
Kas jums vēl būs vajadzīgs
Bakteriostatiskais ūdens tiek automātiski pievienots grozam. Šļirces un salvetes - ar vienu klikšķi.
Insulīna šļirces
10 gab. · 5.50 €
Spirta salvetes
50 gab. · 10 €
Cik daudz ūdens?
Vienības uz šļirces jūsu flakona izmēram.
Atvērt kalkulatoru →Is Tesamorelin approved?
In the US yes, since 2010. The approval is narrow: excess belly fat in adults with HIV and lipodystrophy. Per the US prescribing information it is explicitly not indicated for weight loss. ChEMBL lists Tesamorelin with phase 4 as the highest phase.
How does Tesamorelin differ from growth hormone?
Tesamorelin is not growth hormone. It activates the GHRH receptor of the pituitary, which then releases its own growth hormone in pulses. In response mainly the liver makes more IGF-1. In the first phase 3 trial IGF-1 rose by 81 percent in 26 weeks, on placebo it fell by 5 percent.
What did the phase 3 trials show?
Two trials with more than 800 people with HIV and excess belly fat in total. After 26 weeks visceral fat fell by 15.2 and 10.9 percent, on placebo it rose by 5.0 percent or fell by 0.6 percent. Those on Tesamorelin for a full year were at minus 17.5 percent. Triglycerides fell too, glucose values did not change in a clinically meaningful way on average.
What happens after stopping?
The effect only lasts while Tesamorelin is given. In both phase 3 trials visceral fat quickly returned in those who switched to placebo after 26 weeks. With continued dosing the reduction stayed stable over 52 weeks.
What about liver fat?
In a small study with 50 people with HIV liver fat content fell by a median of 2.0 percentage points in 6 months, on placebo it rose by 0.9. In a second study with fatty liver 35 percent had normal liver fat below 5 percent after twelve months, 4 percent on placebo.
Is there data without HIV?
Few. In a study with 60 people with excess belly fat and low growth hormone release visceral fat fell by 16 square centimetres in twelve months, on placebo it rose by 19. In older adults one study over 20 weeks found a positive effect on executive function. A later study in HIV found no clear difference in cognition.
Which side effects were seen?
Most often injection-site reactions (17 versus 6 percent) and joint pain. Typical effects of more growth hormone such as fluid retention and tingling in the hands came on top. An HbA1c of 6.5 percent or more occurred in 5 percent, 1 percent on placebo. 4 percent had hypersensitivity reactions such as itching or rash.
How long does Tesamorelin stay in the body?
Only briefly. Per the current US prescribing information the half-life after a single dose is about 8 minutes. The trials gave it once a day. IGF-1 stayed raised throughout, by 81 percent on average after 26 weeks.
Saistītie
Saistītie produkti
AOD-9604
Peptīdi · GLP-1 un tauku zudums GLP-1 un tauku zudums
3 izmēri
= no 13.2 €/flakons
MOTS-C
Peptīdi · GLP-1 un tauku zudums GLP-1 un tauku zudums
4 izmēri
Laboratorijā pārbaudīts
= no 16 €/flakons
5-Amino-1MQ
Peptīdi · GLP-1 un tauku zudums GLP-1 un tauku zudums
4 izmēri
Laboratorijā pārbaudīts
= no 10 €/flakons
Adipotide
Peptīdi · GLP-1 un tauku zudums GLP-1 un tauku zudums
3 izmēri
= no 18.8 €/flakons
Tesamorelin